2025 HCPCS Code Q2053
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: viable brexucabtagene positive preparation leukapheresis autologous therapeutic million| Short Description | Brexucabtagene car pos t |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | April 01, 2021 |
| HCPCS Action Effective Date | April 01, 2021 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4297 - Emerge matrix, per sq cm
- Q4298 - Amnicore pro, per sq cm
- Q4299 - Amnicore pro+, per sq cm
- Q4300 - Acesso tl, per sq cm
- Q4301 - Activate matrix, per sq cm
- Q4302 - Complete aca, per sq cm
- Q4303 - Complete aa, per sq cm
- Q4304 - Grafix plus, per sq cm
- Q4305 - Amer am ac tri-lay per sq cm
- Q4306 - Americ amnion ac per sq cm
- Q4307 - American amnion, per sq cm
- Q4308 - Sanopellis, per sq cm
- Q4309 - Via matrix, per sq cm
- Q4310 - Procenta, per 100 mg
- Q4311 - Acesso, per sq cm
- Q4312 - Acesso ac, per sq cm
- Q4313 - Dermabind fm, per sq cm
- Q4314 - Reeva, per sq cm
- Q4315 - Regenelink amniotic mem allo
- Q4316 - Amchoplast, per sq cm